Functional impairment of the arterial wall in primary Sjögren's syndrome: combined action of immunologic and inflammatory factors

scientific article published in May 2010

Functional impairment of the arterial wall in primary Sjögren's syndrome: combined action of immunologic and inflammatory factors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ACR.20117
P698PubMed publication ID20191479
P5875ResearchGate publication ID41624056

P50authorRoberto GerliQ73737873
Yehuda ShoenfeldQ1515807
P2093author name stringElmo Mannarino
Giuseppe Schillaci
Alessia Alunno
Gaetano Vaudo
Elena Bartoloni Bocci
Filippo Luccioli
Raed Hijazi
P2860cites workRegulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cellsQ42475455
P433issue5
P921main subjectSjögren's syndromeQ335555
P304page(s)712-718
P577publication date2010-05-01
P1433published inArthritis Care and ResearchQ15754720
P1476titleFunctional impairment of the arterial wall in primary Sjögren's syndrome: combined action of immunologic and inflammatory factors
P478volume62

Reverse relations

cites work (P2860)
Q34302028An imaging-based approach to the evaluation of xerostomia
Q35951160Arterial Spin Labeling Imaging for the Parotid Glands of Patients with Sjögren's Syndrome
Q37786648Atherosclerotic vascular damage and rheumatoid arthritis: a complex but intriguing link
Q41590963Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study.
Q34081242Cardiovascular involvement in autoimmune diseases
Q37829385Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: a suggested model of preventive strategy
Q92286651Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome
Q58605811Evaluation of subclinical atherosclerosis by ultrasound radiofrequency data technology in patients with primary Sjögren's syndrome
Q36702061Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
Q54060732Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases.
Q49358066Increased risk of coronary heart disease among patients with primary Sjögren's syndrome: a nationwide population-based cohort study
Q37782589Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: Two faces of the same coin
Q48232526Intracranial hemodynamic changes in primary Sjögren syndrome: a transcranial Doppler case-control study
Q44393048Managing comorbidities of inflammatory rheumatic diseases
Q59381498Neovascularization is prominent in the chronic inflammatory lesions of Sjögren's syndrome
Q36721103Primary Sjögren's Syndrome and the Risk of Acute Myocardial Infarction: A Nationwide Study
Q87484514Primary Sjögren's syndrome and risk of ischemic stroke: a nationwide study
Q50935068Relationship of CD146 expression to activation of circulating T cells: exploratory studies in healthy donors and patients with connective tissue diseases.
Q39361426Role of Inflammatory Diseases in Hypertension
Q64105026Subclinical Atherosclerosis in Primary Sjögren's Syndrome: Does Inflammation Matter?
Q35559422Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren's syndrome: prevalence, clinical and laboratory associations
Q50594874Subclinical carotid atherosclerosis in elderly patients with primary Sjögren syndrome: a duplex Doppler sonographic study.
Q30989911The Association Between Sjögren Syndrome and Adverse Postoperative Outcomes: A Historical Cohort Study Using Administrative Health Data
Q89653489Vaginal dryness in primary Sjögren's syndrome: a histopathological case-control study

Search more.